Literature DB >> 11149158

Sick-day management in type 1 diabetes.

L Laffel1.   

Abstract

Illness and stress are common occurrences. For the person with type 1 diabetes, these events can be triggers for counterregulation and [table: see text] subsequent metabolic deterioration if there is no attention to diabetes management tasks. Sick-day management requires increased monitoring of blood glucose and assessment for ketosis. Although urine testing for ketones has been the standard approach to sick-day management, new technology for self-monitoring of blood 3HB levels is now available. According to the American Diabetes Association, blood measurement of 3HB "may offer a useful alternative to urine ketone testing." This new technology may provide an opportunity to improve the management of uncontrolled diabetes and sick days in an attempt to reduce the human and economic burden of DKA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11149158     DOI: 10.1016/s0889-8529(05)70160-2

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  16 in total

1.  Is the formula of Traub still up to date in antemortem blood glucose level estimation?

Authors:  Cristian Palmiere; Frank Sporkert; Paul Vaucher; Dominique Werner; Daniel Bardy; François Rey; Christelle Lardi; Christophe Brunel; Marc Augsburger; Patrice Mangin
Journal:  Int J Legal Med       Date:  2012-02-11       Impact factor: 2.686

Review 2.  Postmortem chemistry update part I.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-09-24       Impact factor: 2.686

Review 3.  Role of beta-hydroxybutyric acid in diabetic ketoacidosis: a review.

Authors:  Vladimir Stojanovic; Sherri Ihle
Journal:  Can Vet J       Date:  2011-04       Impact factor: 1.008

Review 4.  Management of type 1 diabetes in children and adolescents.

Authors:  Vandana Jain
Journal:  Indian J Pediatr       Date:  2013-10-11       Impact factor: 1.967

Review 5.  Blood Ketones: Measurement, Interpretation, Limitations, and Utility in the Management of Diabetic Ketoacidosis.

Authors:  Ketan Dhatariya
Journal:  Rev Diabet Stud       Date:  2017-02-10

Review 6.  Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia.

Authors:  Guillermo Umpierrez; Mary Korytkowski
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

7.  Use of a Combined Blood-Glucose- and ß-Ketone-Measuring Device Improves Glycemic Control in Insulin-Treated Patients With Diabetes: The Gold Plus Study.

Authors:  Ralph Ziegler; Rudolf Eichholz; Birgit Schulz
Journal:  J Diabetes Sci Technol       Date:  2015-05-18

8.  Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology.

Authors:  A Pfützner; D Klonoff; L Heinemann; N Ejskjaer; J Pickup
Journal:  Endocrine       Date:  2017-03-17       Impact factor: 3.633

Review 9.  New technologies and therapeutic approaches for the management of pediatric diabetes.

Authors:  M T Lawlor; L M Laffel
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

Review 10.  Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach.

Authors:  Shilpi Kashyap; Rajni Bala; Reecha Madaan; Tapan Behl
Journal:  Environ Sci Pollut Res Int       Date:  2021-05-21       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.